咳止め薬市場：動向、予測、競合分析（～2030年）

世界の咳止め薬の市場規模は、2024～2030年にかけてCAGR 4.3％で成長すると予測されています。この市場の主な促進要因は、呼吸器系疾患の有病率の上昇、呼吸器系を刺激して咳を引き起こす大気汚染レベルの上昇に伴う咳止め薬の需要増加、便利ですぐに利用できる治療法に対する需要の増加です。咳止め薬の世界市場の将来は、病院、小売薬局、ドラッグストア、オンライン薬局の各市場における機会によって有望視されています。

セグメント別咳止め薬

この調査には、世界の咳止め薬のタイプ別、薬剤タイプ別、剤形別、流通チャネル別、地域別の予測が含まれています。

咳止め薬市場洞察

喉の上部の感染症がますます多くの炎症やくすぐったさを引き起こしているため、乾いた咳の治療薬がより一般的になっているため、予測期間中も乾いた咳がより大きなセグメントであり続けると思われます。

この市場において、小売薬局は引き続き最大のセグメントです。

北米は喉の細菌感染症例の増加により、予測期間中も最大の地域です。

よくある質問

Q1.市場の成長予測は：

A1.世界の咳止め薬市場は、2024～2030年にかけてCAGR 4.3％で成長すると予想されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、呼吸器疾患の有病率の上昇、呼吸器系を刺激し咳の原因となる大気汚染レベルの上昇に伴う咳止め薬の需要の増加、便利で簡単に入手できる治療法に対する需要の増加です。

Q3.市場の主要セグメントは：

A3.世界の咳止め薬市場の将来は、病院、小売薬局、ドラッグストア、オンライン薬局の各市場における機会が有望です。

Q4.市場の主要企業は：

A4.咳止め薬の主要企業は以下の通りです：

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Q5.今後、最大となる市場セグメントは：

A5.予測期間中、乾性咳嗽はより大きなセグメントであり続けると予測しています。これは、喉の上部の感染症がより多くの炎症やくすぐったさを引き起こしているため、乾性咳嗽の治療薬がより普及しているためです。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.北米は、のどの細菌感染症例の増加により、予測期間中も最大の地域です。

Q7.レポートのカスタマイズは可能か：

A7.はい、追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の咳止め薬市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 産業の促進要因と課題

第3章 市場動向と予測分析、2018～2030年

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の咳止め薬市場の動向（2018～2023年）と予測（2024～2030年）
• 世界の咳止め薬市場：タイプ別
  • 乾いた咳
  • 湿生の咳
• 世界の咳止め薬市場：薬剤タイプ別
  • デキストロメトルファン
  • コデイン
  • ノスカピン
  • レボドロプロピジン
  • その他
• 世界の咳止め薬市場：剤形別
  • 固体
  • 液体
  • スプレー
• 世界の咳止め薬市場：流通チャネル別
  • 病院
  • 小売薬局
  • ドラッグストア
  • オンライン薬局
  • その他

第4章 市場動向と予測分析、地域別、2018～2030年

• 世界の咳止め薬市場：地域別
• 北米の咳止め薬市場
• 欧州の咳止め薬市場
• アジア太平洋の咳止め薬市場
• その他の地域の咳止め薬市場

第5章 競合分析

• 製品ポートフォリオ分析
• 業務統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプ別
  • 薬剤タイプ別
  • 剤形別
  • 流通チャネル別
  • 地域別
• 世界の咳止め薬市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の咳止め薬市場の生産能力拡大
  • 世界の咳止め薬市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Cough Suppressant Trends and Forecast

The future of the global cough suppressant market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets. The global cough suppressant market is expected to grow with a CAGR of 4.3% from 2024 to 2030. The major drivers for this market are rising prevalence of respiratory disorders, demand for cough suppressants increases as a result of growing air pollution levels irritating the respiratory system and causing coughing, and increasing demand for convenient and readily available treatments.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Cough Suppressant by Segment

The study includes a forecast for the global cough suppressant by type, drug type, form, distribution channel, and region.

Cough Suppressant Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Dry Cough
• Wet Cough

Cough Suppressant Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

• Dextromethorphan
• Codeine
• Noscapine
• Levodropropizine
• Others

Cough Suppressant Market by Form [Shipment Analysis by Value from 2018 to 2030]:

• Solid
• Liquid
• Spray

Cough Suppressant Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• Others

Cough Suppressant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cough Suppressant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cough suppressant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cough suppressant companies profiled in this report include-

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Cough Suppressant Market Insights

Lucintel forecasts that dry cough will remain larger segment over the forecast period due to remedies for dry coughs are becoming more popular as upper throat infections are causing more and more irritation and tickling.

Within this market, retail pharmacy will remain the largest segment.

North America will remain the largest region over the forecast period due to growing cases of bacterial infection of the throat.

Features of the Global Cough Suppressant Market

Market Size Estimates: Cough suppressant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cough suppressant market size by type, drug type, form, distribution channel, and region in terms of value ($B).

Regional Analysis: Cough suppressant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, drug type, form, distribution channel, and regions for the cough suppressant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cough suppressant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for cough suppressant market?

Answer: The global cough suppressant market is expected to grow with a CAGR of 4.3% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the cough suppressant market?

Answer: The major drivers for this market are rising prevalence of respiratory disorders, demand for cough suppressants increases as a result of growing air pollution levels irritating the respiratory system and causing coughing, and increasing demand for convenient and readily available treatments.

Q3. What are the major segments for cough suppressant market?

Answer: The future of the global cough suppressant market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets.

Q4. Who are the key cough suppressant market companies?

Answer: Some of the key cough suppressant companies are as follows:

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Q5. Which cough suppressant market segment will be the largest in future?

Answer: Lucintel forecasts that dry cough will remain larger segment over the forecast period due to remedies for dry coughs are becoming more popular as upper throat infections are causing more and more irritation and tickling.

Q6. In cough suppressant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing cases of bacterial infection of the throat.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cough suppressant market by type (dry cough and wet cough), drug type (dextromethorphan, codeine, noscapine, levodropropizine, and others), form (solid, liquid, and spray), distribution channel (hospitals, retail pharmacies, drug stores, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cough Suppressant Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Cough Suppressant Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Cough Suppressant Market by Type
  • 3.3.1: Dry Cough
  • 3.3.2: Wet Cough
• 3.4: Global Cough Suppressant Market by Drug Type
  • 3.4.1: Dextromethorphan
  • 3.4.2: Codeine
  • 3.4.3: Noscapine
  • 3.4.4: Levodropropizine
  • 3.4.5: Others
• 3.5: Global Cough Suppressant Market by Form
  • 3.5.1: Solid
  • 3.5.2: Liquid
  • 3.5.3: Spray
• 3.6: Global Cough Suppressant Market by Distribution Channel
  • 3.6.1: Hospitals
  • 3.6.2: Retail Pharmacies
  • 3.6.3: Drug Stores
  • 3.6.4: Online Pharmacies
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Cough Suppressant Market by Region
• 4.2: North American Cough Suppressant Market
  • 4.2.1: North American Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.2.2: North American Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.3: European Cough Suppressant Market
  • 4.3.1: European Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.3.2: European Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.4: APAC Cough Suppressant Market
  • 4.4.1: APAC Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.4.2: APAC Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.5: ROW Cough Suppressant Market
  • 4.5.1: ROW Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.5.2: ROW Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cough Suppressant Market by Type
  • 6.1.2: Growth Opportunities for the Global Cough Suppressant Market by Drug Type
  • 6.1.3: Growth Opportunities for the Global Cough Suppressant Market by Form
  • 6.1.4: Growth Opportunities for the Global Cough Suppressant Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Cough Suppressant Market by Region
• 6.2: Emerging Trends in the Global Cough Suppressant Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cough Suppressant Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cough Suppressant Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Acella Pharmaceuticals
• 7.3: GlaxoSmithKline
• 7.4: Johnson & Johnson Services
• 7.5: Merck
• 7.6: Novartis International
• 7.7: Pfizer
• 7.8: Procter & Gamble
• 7.9: Reckitt Benckiser Group
• 7.10: Sanofi